Omvoh (mirikizumab-mrkz intravenous infusion) — Medica
Ulcerative colitis
Initial criteria
- age ≥ 18 years
- medication will be used as induction therapy
- Prescribed by or in consultation with a gastroenterologist
Approval duration
3 months
Ulcerative colitis
3 months